Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Geriatrics | Neurology | Nursing | Psychiatry | Journal

Back to Journal Articles

Mortality Predictors for Parkinson’s Disease Identified

Last Updated: October 05, 2010.

 

Dementia, psychosis, motor severity, and age at onset among independent predictors

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Age at onset, chronological age, presence of dementia, motor severity, and psychosis are among the independent factors predictive of mortality in Parkinson's disease patients, according to research published in the Oct. 5 issue of Neurology.

TUESDAY, Oct. 5 (HealthDay News) -- Age at onset (AAO), chronological age, presence of dementia, motor severity, and psychosis are among the independent factors predictive of mortality in Parkinson's disease (PD) patients, according to research published in the Oct. 5 issue of Neurology.

Elin Bjelland Forsaa, M.D., of the Stavanger University Hospital in Norway, and colleagues analyzed assessments of motor and non-motor symptoms from 1993 to 2005 in 230 patients with PD to identify risk factors for mortality during a long-term follow-up.

The researchers found AAO, chronological age, male sex, Unified Parkinson's Disease Rating Scale motor score, psychotic symptoms, and dementia to be independent predictors of mortality; 211 patients (92 percent) died during the study period, and the median survival time from onset of motor symptoms was 15.8 years, ranging from 2.2 to 36.6 years.

"This population-based long-term study demonstrates that in addition to AAO, chronological age, motor severity, and dementia, psychotic symptoms independently predict increased mortality in PD. In contrast, no significant impact of antipsychotic or antiparkinsonian drugs on survival was observed in our PD cohort. Early prevention of motor progression and development of psychosis and dementia may be the most promising strategies to increase life expectancy in PD," the authors write.

Two authors disclosed financial relationships with pharmaceutical companies.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2010 HealthDay. All rights reserved.


Previous: Study Validates Noninvasive Blood Test for CAD Next: Age at Cancer Diagnosis Similar in AIDS, General Populations

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.